Evidence map›Paper›PMID 38557235›Full record

ArticleAntimicrobial agents and chemotherapy2024

Thais Martins-Gonçalves, Julia S Pimenta, Herrison Fontana, Fernanda Esposito, Gregory Melocco, Karine Dantas, Felipe Vásquez-Ponce, Floristher E Carrara, Eliana C Vespero, Nilton Lincopan

Abstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Emergence of carbapenem-resistantAntimicrobial agents and chemotherapy · 2025
    Article
  4. Carbapenem-ResistantMicroorganisms · 2025
    Review
  5. Genomic characterization of multidrug-resistant clinicalFrontiers in cellular and infection microbiology · 2025
    Article
  6. Exploring the clinical outcomes and molecular characteristics ofFrontiers in cellular and infection microbiology · 2025
    Article
  7. Treatment Strategies of Colistin ResistanceAntibiotics (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thais Martins-Gonçalves *Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Julia S Pimenta *Department of Pathology, Clinical and Toxicological Analysis, Center for Health Sciences, State University of Londrina, Paraná, Brazil.
Herrison FontanaOne Health Brazilian Resistance Project (OneBR), São Paulo, Brazil.ORCID 0000-0003-2057-6472
Fernanda EspositoOne Health Brazilian Resistance Project (OneBR), São Paulo, Brazil.
Gregory MeloccoOne Health Brazilian Resistance Project (OneBR), São Paulo, Brazil.
Karine DantasOne Health Brazilian Resistance Project (OneBR), São Paulo, Brazil.
Felipe Vásquez-PonceDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Floristher E CarraraDepartment of Pathology, Clinical and Toxicological Analysis, Center for Health Sciences, State University of Londrina, Paraná, Brazil.ORCID 0000-0002-9573-9582
Eliana C VesperoDepartment of Pathology, Clinical and Toxicological Analysis, Center for Health Sciences, State University of Londrina, Paraná, Brazil.
Nilton LincopanDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-0161-5800

Funding

Bill and Melinda Gates Foundation (GF) OPP1193112Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 422984/2021-3,314336/2021-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 88887.702869/2022-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 88887.714992/2022-00Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2019/15578-4Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2020/08224-9
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial Agentsbeta-LactamasesMicrobial Sensitivity TestsHumansSouth AmericaAnti-Bacterial Agentsbeta-lactamase NDM-1beta-lactamase OXA-23beta-Lactamasescarbapenemase co-productioncritical-priority pathogengenomic surveillanceInternational clone IILatin Americamethyltransferase

Identifiers

PMID38557235
PMCPMC11064515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.